Looking Ahead 2022
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Looking Ahead 2022
-
Narrated by:
-
By:
2021 was a wild ride for biotechnology companies and 2022 is shaping up with some interesting trends that will take biotech into both significant headwinds and opportunities. Sam Falsetti, Global Chief Biotechnology Officer for MEDiSTRAVA, hosts a wide-ranging discussion with two of his executive colleagues. He is joined by Phil Wakefield, the Global Chief Advisory and Evidence Communications Officer for the MEDiSTRAVA group, and Rachel Hatfield, a Managing Partner at MEDiSTRAVA Consulting. They discuss a wide array of topics including lessons learned from 2021, crystal ball predictions for 2022, and key trends that biotech executives should take into account when planning for organizational growth and asset development.
adbl_web_anon_alc_button_suppression_c
No reviews yet